Insmed Accrued Royalties decreased by 0.4% to $162.14M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.2%, from $162.51M to $162.14M.
other_accrued_royalties_current_and_noncurrent| Q4 '21 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $148.02M | $150.17M | $152.02M | $153.43M | $155.03M | $156.97M | $158.38M | $160.05M | $161.07M | $162.51M | $163.53M | $163.85M | $162.87M | $162.14M |
| QoQ Change | — | — | +1.5% | +1.2% | +0.9% | +1.0% | +1.2% | +0.9% | +1.1% | +0.6% | +0.9% | +0.6% | +0.2% | -0.6% | -0.4% |
| YoY Change | — | — | — | — | — | +4.7% | +4.5% | +4.2% | +4.3% | +3.9% | +3.5% | +3.3% | +2.4% | +1.1% | -0.2% |